Atrium Innovations, a globally recognized leader in the development, manufacturing and commercialization of innovative, science-based, natural health products, and Permira, the global investment firm, today announced that Atrium will be acquired by Nestlé from a group of investors including a company backed by the Permira Funds, Fonds de solidarité FTQ and Caisse de dépôt et placement du Québec, for USD 2.3 billion in cash.
Atrium is a world-wide leader in nutritional supplements and one of the fastest growing companies in the industry globally. Its brands and business model are complementary with Nestlé’s science-based nutritionalsolutions for consumers, patients, doctors, nurses and other partners in healthcare. With Nestlé’s significant resources, scale, breadth and capabilities, Atrium will continue to expand its brands and compete even more effectively in the global marketplace. Upon closing, Atrium will become an independent operating division within the Nestlé Health Science business. The Company will continue to operate as it has prior to the acquisition, with no changes to its strong brands and primary locations globally.
Click below to download the full release.